US$ 27.32
weight loss glp 1 agonists GLP-1 Drugs Market Report, 2025-2030 How GLP-1 Receptor Agonists Evolved
Description
We forecast one to two GLP-1 launches annually starting in 2026, with the first oral entrant expected by 2027

These drugs mimic natural gut hormones to slow digestion, reduce appetite, and improve blood sugar control

While GLP-1 receptor agonists have revolutionized the way we approach weight loss and diabetes management, their impact goes far beyond a number on the scale

and semaglutide (brand name Wegovy) followed in 2021

Youre comfortable with potentially slightly higher side effect rates for better results
